These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7297801)

  • 21. High prevalence of functional liver derangement in visceral leishmaniasis at an Indian tertiary care center.
    Mathur P; Samantaray JC; Samanta P
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1170-2. PubMed ID: 18619918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh.
    Bern C; Amann J; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Wagatsuma Y; Breiman RF; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2006 Oct; 75(4):744-8. PubMed ID: 17038705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations.
    Ramesh V
    Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis.
    Ansari NA; Ramesh V; Salotra P
    J Infect Dis; 2006 Oct; 194(7):958-65. PubMed ID: 16960784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculin sensitivity in kala-azar.
    Sharma VK; Jha TK
    J Indian Med Assoc; 1987 Feb; 85(2):61. PubMed ID: 3611825
    [No Abstract]   [Full Text] [Related]  

  • 26. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review.
    Hernández-Pérez J; Yebra-Bango M; Jiménez-Martínez E; Sanz-Moreno C; Cuervas-Mons V; Alonso Pulpón L; Ramos-Martínez A; Fernández-Fernández J
    Clin Infect Dis; 1999 Oct; 29(4):918-21. PubMed ID: 10589910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?
    Mendiratta V; Chander R
    Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An atypical course of visceral leishmaniasis (Kala-azar) in a liver transplant recipient.
    Clemente WT; Couto CA; Ribeiro DD; de Medeiros Chaves França M; Sanches MD
    Transplantation; 2007 Feb; 83(3):368-9. PubMed ID: 17297421
    [No Abstract]   [Full Text] [Related]  

  • 30. [Unusual infectious diseases in a municipal hospital (author's transl)].
    Biller H; Moll A; Wandt H
    MMW Munch Med Wochenschr; 1976 Nov; 118(45):1457-60. PubMed ID: 825760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outbreak of kala-azar in Bombay.
    Bhatia S; Patel N; Gulhane S; Dongre V; Jijina FF; Pathare AV
    J Postgrad Med; 1995; 41(1):3-4. PubMed ID: 10740690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kala-azar in the adult].
    Oren E; Lieberman D; Basan L; Alroy G
    Harefuah; 1983 Dec; 105(11):363-4. PubMed ID: 6671577
    [No Abstract]   [Full Text] [Related]  

  • 33. Lymphoma as a cause of false positive serology for visceral leishmaniasis (kala-azar) using the indirect haemagglutination (IHA) method.
    Malik GM; Abdalla RE; al-Knawy B; Abdalla SE
    J Trop Med Hyg; 1995 Aug; 98(4):285-6. PubMed ID: 7636928
    [No Abstract]   [Full Text] [Related]  

  • 34. [A patient with unclear febrile state caused by visceral leishmaniasis (author's transl)].
    Gjurasin M; Husar J; Hulina D
    Lijec Vjesn; 1978 May; 100(5):307-8. PubMed ID: 682836
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.
    Ismail A; El Hassan AM; Kemp K; Gasim S; Kadaru AE; Moller T; Kharazmi A; Theander TG
    J Pathol; 1999 Dec; 189(4):615-22. PubMed ID: 10629566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal.
    Rijal S; Boelaert M; Regmi S; Karki BM; Jacquet D; Singh R; Chance ML; Chappuis F; Hommel M; Desjeux P; Van der Stuyft P; Le Ray D; Koirala S
    Trop Med Int Health; 2004 Jun; 9(6):724-9. PubMed ID: 15189464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis.
    Kurkjian KM; Mahmutovic AJ; Kellar KL; Haque R; Bern C; Secor WE
    Cytometry A; 2006 May; 69(5):353-8. PubMed ID: 16604536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.